Trabeculectomy With MMC Versus Ahmed Glaucoma Implant for Treatment of Pediatric Aphakic Glaucoma

Shahid Beheshti University of Medical Sciences

Overview

In this randomized clinical trial we compare trabeculectomy with mitomycin-C (T+MMC) and Ahmed glaucoma implant (AGI) in treatment of aphakic glaucoma in children under 16 years of age.Complete and qualified success were defined as 5≤IOP≤21mmHg without and with medication respectively and we came to this point that; T+MMC and AGI are comparable in terms of success rate and complications in pediatric aphakic glaucoma.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Conditions

Pediatric Aphakic Glaucoma

Interventions

trabeculectomy with mitomycin-CPROCEDURE

Eligibility

Sex: ALLMin age: 0 YearsMax age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: * congenital cataract * history of cataract surgery * under 16 years old * Ocular pressure more than 21 mmHg Exclusion Criteria: * interruption of the follow up before 6 month * Anterior segment dysgenesis

Locations (1)

Ophthalmic Research Center

Tehran, Tehran Province, Iran

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.